SMMGP Premium Membership BENEFITS SMMGP Premium Membership provides a minimum of 15 hours of high quality continuing professional development (CPD) per year on a range of relevant topics in the addictions field. Benefits include: Regular clinical and policy updates Webinars Special offers including discounts on selected training events and products Webinars Our webinars cover up-to-date issues that practitioners face, delivered by experts. See our future webinars. Webinars from the last 18 months which can be watched immediately by joining Premium Membership include: Chemsex: the key issuesOwen Bowden-Jones will take us through the key issues to consider regarding chemsex, the taking of drugs specifically to enhance sex, usually by men who have sex with men. Problem GamblingAndré Geel, Consultant Clinical Psychologist, will cover the following: gambling as a public health issue, prevalence, how to identify problem gambling, and what's the best intervention and treatment. Benzodiazepines - the trickiest issue in the field? Dr Martyn Hull on working with problematic benzodiazepine use including risks, harms and detoxification. So you want me to prescribe dexamphetamine? Graham Parsons, Consultant Clinical Pharmacist on What makes an NMP a specialist in the modern day substance misuse services? and the issues regarding competencies and the increasingly important role of the Non Medical Prescriber. Setting up Hepatitis C care pathways Dr Carola Sander-Hess, Medical Lead Inclusion discusses hepatitis C carepathways and how to make them work including how to engage clients into treatment. Responding to the misuse of fentanyl Dr Prun Bijral , Medical Director CGL discusses the issues relating to the worrying trend of fentanyl use, and will outline how services can respond. Opioid analgesic dependence in pain patients Dr Jane Quinlan Consultant in Anaesthesia and Pain Management on the complex issues involved in pain management and opioid dependence drawing onher experience. Alcohol problems working with complex needs Dr Martyn Hull, Clinical Director, Turning Point discusses some of the grey areas clinicians face when working with people with problematic alcohol use. Novel Psychoactive Substances - sharing prison and community experiences and good practice Dr George Ryan, Clinical Advisor Public Health England, Criminal Justice Team, Drugs, Alcohol and Tobacco Division on the issues of NPS in prison and community settings and guide us as to what can be learnt from this. Opioid substitute treatment and dose optimisation: how to get it right Dr Steve Brinksman on the evidence and practice of how to get the OST dose right. He draws on guidance and his experience of working in the field to discuss the difficulties of finding the right dose for patients. Improving lung health in those who misuse substances Dr. Aadil Shah,Regional Lead Consultant Psychiatrist, CGL discusses how to improve lung health amongst a group who have a high prevalence of lung disease. Clinical updates Thomas Jones, Service Lead for the Alcohol Care Team at King's College Hospital is our Clinical update editor. Every 3 months he provides summaries of the most recent research and provides commentary on what it means for the field. For tasters of clinical updates.